ABLYNX WILL ANNOUNCE HALF YEAR RESULTS FOR 2011 WITH WEBCAST

ABLYNX WILL ANNOUNCE HALF YEAR RESULTS FOR 2011 WITH WEBCAST

ID: 57389

(Thomson Reuters ONE) -


GHENT, Belgium, 18 August 2011 - Ablynx [Euronext Brussels: ABLX] plans to
announce its half year results for 2011 on 25 August 2011 after market closure.

Dr Edwin Moses, CEO and Chairman of Ablynx, will host a conference call webcast
during which the half year results for 2011 will be presented, followed by a Q&A
session. This event will be held on Friday, 26 August 2011 at 4.00 p.m. CET.

The conference call will be webcast live and may be accessed on the home page of
the Ablynx website at www.ablynx.com. Shortly thereafter, a replay of the
webcast will be available on the Company's website.

To ensure a timely connection, it is recommended that users register at least
10 minutes prior to the scheduled webcast.



About Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development
of Nanobodies(®), a novel class of therapeutic proteins based on single-domain
antibody fragments, for a range of serious and life-threatening human diseases,
including inflammation, thrombosis, oncology and pulmonary disease. Today, the
Company has over 25 projects in the pipeline and there are seven Nanobodies in
clinical development. Ablynx has ongoing research collaborations and significant
partnerships with major pharmaceutical companies, including Boehringer
Ingelheim, Merck Serono, Novartis and Pfizer. The Company is headquartered in
Ghent, Belgium and currently employs over 280 people. More information can be
found on www.ablynx.com.



For more information, please contact Ablynx:

Dr Edwin Moses
Chairman and CEO
t:   +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
     +32 (0)473 39 50 68
e: edwin.moses(at)ablynx.com

Marieke Vermeersch
Investor Relations Manager
t:   +32 (0)9 262 00 82




m: +32 (0)479 49 06 03
e: marieke.vermeersch(at)ablynx.com




Complete version of the press release:
http://hugin.info/137912/R/1539425/470461.pdf




This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Ablynx via Thomson Reuters ONE

[HUG#1539425]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  SHARE REPURCHASE 18.8.2011 Spectraseis Wins $3.6 Million Investment From Credit Suisse
Bereitgestellt von Benutzer: hugin
Datum: 18.08.2011 - 18:00 Uhr
Sprache: Deutsch
News-ID 57389
Anzahl Zeichen: 2757

contact information:
Town:

Ghent



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 147 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ABLYNX WILL ANNOUNCE HALF YEAR RESULTS FOR 2011 WITH WEBCAST"
steht unter der journalistisch-redaktionellen Verantwortung von

Ablynx (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Ablynx Announces Half-Year Results for 2013 ...

GHENT, BELGIUM -- (Marketwired) -- 08/21/13 -- (EURONEXT BRUSSELS: ABLX) today announced its results for the six-month period ending 30 June 2013, which have been prepared in accordance with the IAS 34 "Interim Financial Reporting" as adop ...

Ablynx Announces Warrant Exercise ...

GHENT, BELGIUM -- (Marketwired) -- 07/23/13 -- (EURONEXT BRUSSELS: ABLX) today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 273,913 common shares have been issued by the ...

Alle Meldungen von Ablynx



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z